A biotechnology company developing RNA technologies to shape the future of gene therapy
Shape Therapeutics has raised $112.0M in total funding. The most recent round was Grant. The last funding was announced in July 2026.
Shape Therapeutics's investors include New Enterprise Associates, Michael J. Fox Foundation, Decheng Capital, Mission BioCapital, Cherubic Ventures.
Shape Therapeutics is headquartered in Seattle, United States.
A biotechnology company developing RNA technologies to shape the future of gene therapy
Shape Therapeutics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Shape Therapeutics — Funding & Investors." VCBacked, July 29, 2026, https://www.vcbacked.co/company/shape-therapeutics. Accessed October 27, 2026.
VCBacked. (2026). Shape Therapeutics — Funding & Investors. Retrieved October 27, 2026, from https://www.vcbacked.co/company/shape-therapeutics
{{cite web |title=Shape Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/shape-therapeutics |website=VCBacked |access-date=October 27, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated